National Pension Service raised its position in Humana Inc. (NYSE:HUM – Free Report) by 2.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 189,601 shares of the insurance provider’s stock after purchasing an additional 5,150 shares during the quarter. National Pension Service owned 0.16% of Humana worth $49,328,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Elevation Point Wealth Partners LLC acquired a new stake in Humana during the 2nd quarter worth approximately $32,000. Mather Group LLC. bought a new position in shares of Humana during the third quarter valued at $34,000. AlphaCore Capital LLC bought a new position in shares of Humana during the second quarter valued at $39,000. Private Wealth Management Group LLC lifted its holdings in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares during the period. Finally, SJS Investment Consulting Inc. grew its stake in shares of Humana by 19,300.0% in the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after purchasing an additional 193 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.
Humana Trading Down 0.8%
Shares of HUM stock opened at $195.15 on Monday. Humana Inc. has a fifty-two week low of $191.39 and a fifty-two week high of $315.35. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The stock has a 50 day simple moving average of $256.45 and a two-hundred day simple moving average of $264.29. The company has a market cap of $23.47 billion, a P/E ratio of 18.29, a PEG ratio of 1.61 and a beta of 0.44.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on HUM shares. Wolfe Research raised their target price on Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Thursday, January 8th. Wells Fargo & Company downgraded Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Robert W. Baird cut their price objective on Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a research note on Thursday, December 11th. KeyCorp reissued a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Finally, Zacks Research lowered shares of Humana from a “hold” rating to a “strong sell” rating in a report on Thursday, January 1st. Eight equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $293.21.
View Our Latest Stock Analysis on Humana
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Recommended Stories
- Five stocks we like better than Humana
- Trump just signed it
- GOLD ALERT
- What Expenses Can Be Deducted From Capital Gains Tax?
- Buy this Gold Stock Before May 2026
- The day the gold market broke
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
